Autonomix Medical Inc (AMIX): Not A Time To Panic Nor Freeze

Autonomix Medical Inc (AMIX) concluded trading on Thursday at a closing price of $1.90, with 3.48 million shares of worth about $6.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.16% during that period and on May 15, 2025 the price saw a gain of about 9.20%. Currently the company’s common shares owned by public are about 2.46M shares, out of which, 1.94M shares are available for trading.

Stock saw a price change of 11.76% in past 5 days and over the past one month there was a price change of 13.77%. Year-to-date (YTD), AMIX shares are showing a performance of -49.47% which decreased to -96.44% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.52 but also hit the highest price of $56.00 during that period. The average intraday trading volume for Autonomix Medical Inc shares is 75.65K. The stock is currently trading -3.74% below its 20-day simple moving average (SMA20), while that difference is down -1.83% for SMA50 and it goes to -72.49% lower than SMA200.

Autonomix Medical Inc (NASDAQ: AMIX) currently have 2.46M outstanding shares and institutions hold larger chunk of about 18.88% of that.

The stock has a current market capitalization of $4.68M and its 3Y-monthly beta is at -3.37. It has posted earnings per share of -$12.53 in the same period. It has Quick Ratio of 5.31 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMIX, volatility over the week remained 8.74% while standing at 9.71% over the month.

Analysts are in expectations that Autonomix Medical Inc (AMIX) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 60.65% while it is estimated to decrease by -8.47% in next year.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.